LPM-787000048
- Generic Name
- LPM-787000048
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
Phase 1
Not yet recruiting
- Conditions
- SchizophreniaAlzheimer's Disease Psychosis
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Luye Pharma Group Ltd.
- Target Recruit Count
- 66
- Registration Number
- NCT06556966
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath